📈 FDA Doctor Says Get Booster Even After 2 Doses & COVID + New Kaiser Myocarditis Pericarditis Data In Kids
🏥 FDA Doctor Says Get Booster Even After 2 Doses & COVID
Earlier I posted a tweet after an interesting video surfaced of the FDA CBER Director Dr. Peter Marks speaking about boosters. He said everyone should get a booster, even if they’ve been vaccinated with 2 doses and had COVID-19 because it increases antibodies.
To be specific, Dr. Marks claimed that boosters provide high levels of antibodies against the currently circulating Omicron strain and future strains of SARS-CoV-2 which are key to optimal immunity. That said, there is no science to back up such a claim.
First of all, antibodies generated from Pfizer, Moderna, and J&J are engineered to fight the original strain, not the new and highly mutated omicron. That’s why there are a substantial amount of breakthrough infections in vaccinated individuals right now.
Next, just because a person has high neutralizing IgG antibody titers doesn’t mean they have better immunity. You see, antibody titers can be high, but again, if they’re targeting a different variant they won’t be as effective. Quantity doesn’t translate to quality.
Also, antibodies disappear as the body generates many T and B cells which provide robust, lasting immunity against SARS-CoV-2 long after antibodies have vanished. T and B cells are longer lived, and are an amazing source of broad protection.
It seems our public health officials are stuck on dogmatic medical ideologies. That is bad because current science shows us there’s way more to immunity than just high antibody levels, and boosting everyone just because.
👉🏻Click here to see my full tweet and video on this matter👈🏻
👦🏻 New Kaiser Myocarditis Pericarditis After COVID-19 mRNA Vaccination Data In Kids
New myocarditis/pericarditis data was released by Kaiser Permanente Northwest. It found many extra cases that were overlooked using a 3 part investigative approach.
First, cases were searched using myocarditis billing codes like ICD-10-CM I40.9 which is unspecified myocarditis, and pericarditis billing codes. That is important because using billing codes to find specific kinds of disease narrows down the search when other normal methods yield lesser results. That evidenced by the researchers in this study finding many extra myocarditis and pericarditis cases that were overlooked by traditional search methods.
Second, the text summary of each encounter regarding every in and outpatient visit was searched for the words “myocarditis” or “pericarditis”. Sometimes the names won’t show up as diagnosis, but will show up in the body of text describing the encounter with the patient.
Third, emergency department visits, and hospitalizations of Kaiser patients were examined for discharge diagnosis of myocarditis and pericarditis.
The researcher’s methods in this study were brilliant. Basically, they used a specific billing code to pinpoint cases. Then they looked through all the doctors notes to see if the words myocarditis or pericarditis were used. Finally, they examined all the emergency department, and hospitalization data of their patients to see if they received a diagnosis of myocarditis or pericarditis that wasn’t reported to the Kaiser system.
The crunched numbers revealed some harrowing figures:
There were 377.4 cases per million of myocarditis/pericarditis in male children aged 12-17 after the second dose of an mRNA COVID-19 vaccine (Moderna & Pfizer). That translates to 1 in every 2,700.
There were 537.1 cases per million of myocarditis/pericarditis in male children aged 12-17 after the second dose of an mRNA COVID-19 vaccine (Moderna & Pfizer). That translates to 1 in every 1,900.
📌 Just so we’re clear, 1/2,700, 1/1,900 is by no means rare. On the contrary, it means children are experiencing substantially higher rates of myocarditis and pericarditis than any other cohort.
Now, i’ll leave you with some good news. That is, there are things that can be done about this and I speak specifically about them in previous publications that you can read by clicking here, and here.
LETS CONNECT: